The frequency of naive CD8+ T cells was also lower among hospitalized subjects, suggesting increased differentiation to an effector phenotype in severe COVID-19; however, no difference in the frequency of naive CD4+ T cells was observed between groups (Figure 1H). The gene discussed is CD4; the disease is COVID-19.